Effect of transforming growth factor-beta1 on interleukin-6 secretion in human myoblasts

J Neuroimmunol. 1998 Jul 1;87(1-2):185-8. doi: 10.1016/s0165-5728(98)00110-6.

Abstract

Transforming growth factor-beta (TGF-beta) is involved in several autoimmune neurological diseases. It is still unclear whether its local action can be pro-inflammatory or anti-inflammatory in the muscle tissue, because of the few reports on this subject. We have previously shown that human myoblasts secrete interleukin-6 (IL-6) when stimulated with inflammatory cytokine such as interleukin-1beta (IL-1beta) or tumor necrosis factor alpha. In the present report, we show that TGF-beta1 can induce IL-6 production; moreover, costimulation or short term pre-incubation with TGF-beta1 increases IL-1beta effect, while a longer incubation inhibits its action.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Drug Synergism
  • Humans
  • Interleukin-1 / pharmacology
  • Interleukin-6 / metabolism*
  • Muscles / cytology
  • Muscles / drug effects
  • Muscles / metabolism*
  • Time Factors
  • Transforming Growth Factor beta / pharmacology*

Substances

  • Interleukin-1
  • Interleukin-6
  • Transforming Growth Factor beta

Grants and funding